Post-transplant immunotherapy with WT1-specific CTLs for high-risk acute myelogenous leukemia: a prospective clinical phase I/II trial

Bone Marrow Transplant. 2019 Jun;54(6):903-906. doi: 10.1038/s41409-018-0383-2. Epub 2018 Nov 8.

¹ Leukemia Research Institute, Seoul St. Mary's Hematology Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
² Catholic Hematopoietic Stem Cell Bank, College of Medicine, The Catholic University of Korea, Seoul, Korea.
³ Department of Microbiology, College of Medicine, The Catholic University of Korea, Seoul, Korea.
⁴ Catholic Hematopoietic Stem Cell Bank, College of Medicine, The Catholic University of Korea, Seoul, Korea. [email protected].
⁵ Department of Microbiology, College of Medicine, The Catholic University of Korea, Seoul, Korea. [email protected].

No abstract available

Publication types